Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

1(33.3%)

N/A

1(33.3%)

Phase 1

1(33.3%)

3Total

Phase 4(1)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05166850Not ApplicableRecruiting

Preventative Intervention for Cholera for 7 Days

Role: collaborator

NCT06450379Completed

Impact of Vaccines on Antimicrobial Microbial Resistance

Role: collaborator

NCT03282903Completed

The PRognostic Effect of Environmental Factors in Crohn's and Colitis

Role: collaborator

NCT05072613Completed

Monitoring Pregnant Women for Antimalarial Drug Resistance

Role: collaborator

NCT03587389Phase 4Completed

Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam

Role: collaborator

NCT03709862Completed

Global Syphilis Sequencing

Role: collaborator

NCT02739763Phase 1Unknown

Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)

Role: collaborator

All 7 trials loaded